Findings from a recent study of nearly 4,500 patients hospitalized with COVID-19 over a four-month period provide a stronger case for a very different conclusion: Statins likely did not confer any impact -- positive or negative -- on COVID-related mortality and may be associated with an significantly increased risk -- nearly 1 chance in 5 -- of more serious illness.